Aeterna Zentaris to Present at Cowen and Company 32nd Annual Health Care Conference in Boston

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\n\n\n\nQUÉBEC CITY, Feb. 29, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") today announced that its Senior Vice\n President and Chief Medical Officer,\n\n\nPaul Blake, MD, will be presenting a corporate overview at the Cowen and\n Company 32nd Annual Health Care Conference on Wednesday, March 7, 2012, at 8:40 am\n (Eastern), at the Boston Marriott Copley Place in Boston, MA.\n\n\nA live audio webcast of this presentation will be available on Aeterna\n Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcasts will also be\n available on the Company's website for a period of 90 days.\n\n\nAbout Aeterna Zentaris Inc.\n\n\nAeterna Zentaris is a late-stage oncology drug development company\n currently investigating potential treatments for various cancers\n including colorectal, multiple myeloma, endometrial, ovarian, prostate\n and bladder cancer. The Company's innovative approach of \"personalized\n medicine\" means tailoring treatments to a patient's specific condition\n and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn\n from its proprietary discovery unit providing the Company with constant\n and long-term access to state-of-the-art therapeutic options. For more\n information please visit www.aezsinc.com.\n\n\n\n Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. [email protected] Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. [email protected] \n","length":1810,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.